Literature DB >> 17669303

[Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy].

F A Fernández1, E Pintor, R Quesada, F J Garcés.   

Abstract

Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) have been associated with some drugs, particularly anticonvulsants such as phenytoin. Some authors have pointed out an increased risk of TEN/SJS when phenytoin is associated with whole brain radiotherapy. We report a patient diagnosed with breast adenocarcinoma and brain metastases that was on treatment with phenytoin and, shortly after receiving whole brain radiotherapy, developed toxic epidermal necrolysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669303     DOI: 10.1016/s1578-2190(07)70492-4

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  5 in total

1.  Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy.

Authors:  M Maschio; L Dinapoli; A Vidiri; Paola Muti
Journal:  J Neurol       Date:  2010-07-08       Impact factor: 4.849

2.  Toxic epidermal necrolysis in hemodialysis patient.

Authors:  Uday Venkat Mateti; Shankar Prasad Nagaraju; Manohar Bairy; Ravindra Prabhu Attur; Anantha Naik Nagappa; Anuradha Calicut Kini Rao
Journal:  Adv Biomed Res       Date:  2015-02-27

3.  Phenytoin- and cranial radiotherapy-induced toxic epidermal necrolysis treated with combination therapy: systemic steroid and intravenous immunoglobulin.

Authors:  E Fidan; M Fidan; F Ozdemir; H Kavgaci; F Aydin
Journal:  Med Oncol       Date:  2011-02-24       Impact factor: 3.064

4.  Toxic Epidermal Necrolysis Following Phenytoin and Cranial Irradiation.

Authors:  Najeeba Riyaz; Sarita Sasidharanpillai; Saleem Rahima; Maniyan M Kavitha
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

Review 5.  Phenytoin-induced toxic epidermal necrolysis: Review and recommendations.

Authors:  Osama M Al-Quteimat
Journal:  J Pharmacol Pharmacother       Date:  2016 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.